ATN-161   Click here for help

GtoPdb Ligand ID: 14587

Synonyms: ATN161 | N-acetyl-L-prolyl-L-histidyl-L-seryl-L-cysteinyl-L-asparaginamide
Compound class: Peptide
Comment: ATN-161 is a penta-peptide integrin α5β1 antagonist [5]. It interferes with the interaction between the integrin on endothelial cells and fibronection in the extracellular matrix (ECM) [3]. ATN-161 was primarily proposed as an anti-tumour agent with potential to disrupt neoangiogenesis [1,5,7]. It has subsequently been explored for antimicrobial/anti-infection potential [2,4,6,9].
Click here for help
2D Structure
Click here for help
Click here for structure editor
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC2=CN=CN2)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)N)C(=O)N
Isomeric SMILES CC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC2=CN=CN2)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)N)C(=O)N
InChI InChI=1S/C23H35N9O8S/c1-11(34)32-4-2-3-17(32)23(40)29-14(5-12-7-26-10-27-12)20(37)30-15(8-33)21(38)31-16(9-41)22(39)28-13(19(25)36)6-18(24)35/h7,10,13-17,33,41H,2-6,8-9H2,1H3,(H2,24,35)(H2,25,36)(H,26,27)(H,28,39)(H,29,40)(H,30,37)(H,31,38)/t13-,14-,15-,16-,17-/m0/s1
InChI Key MMHDBUJXLOFTLC-WOYTXXSLSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

No information available.
Summary of Clinical Use Click here for help
ATN-161 was progressed as a clinical anti-tumour agent.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT00131651 ATN-161 in Advanced Renal Cell Cancer Phase 2 Interventional Attenuon
NCT00352313 ATN-161 and Carboplatin in Treating Patients With Recurrent Malignant Glioma Phase 1/Phase 2 Interventional National Institutes of Health Clinical Center (CC)